MetAlert Inc. (MLRT) Announces Canadian Distributor Launch of Award-Winning 4G GPS SmartSole Medical Monitoring Device for Alzheimer’s, Dementia, and Autism
ARPA-H is investing a billion dollars to encourage cutting-edge research for Alzheimer's, supporting bold ideas to pursue and drive new biomedical breakthroughs The Department of Health and Human Services is investing in research and technology to help keep Alzheimer's patients in their homes longer, train caregivers to support them, and educate Americans about Alzheimer's early warning signs – all of which MetAlert provides products and solutions for The Alzheimer’s Disease diagnostic and therapeutic market is expected to reach an estimated $9.6 billion by 2027 MetAlert (OTC: MLRT), a pioneer in location-sensitive health monitoring devices and wearable technology products, has announced…